Abstract

Whole blood transcriptional signatures distinguishing active tuberculosis patients from asymptomatic latently infected individuals exist. Consensus has not been achieved regarding the optimal reduced gene sets as diagnostic biomarkers that also achieve discrimination from other diseases. Here we show a blood transcriptional signature of active tuberculosis using RNA-Seq, confirming microarray results, that discriminates active tuberculosis from latently infected and healthy individuals, validating this signature in an independent cohort. Using an advanced modular approach, we utilise the information from the entire transcriptome, which includes overabundance of type I interferon-inducible genes and underabundance of IFNG and TBX21, to develop a signature that discriminates active tuberculosis patients from latently infected individuals or those with acute viral and bacterial infections. We suggest that methods targeting gene selection across multiple discriminant modules can improve the development of diagnostic biomarkers with improved performance. Finally, utilising the modular approach, we demonstrate dynamic heterogeneity in a longitudinal study of recent tuberculosis contacts.

Details

Title
A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection
Author
Singhania, Akul 1   VIAFID ORCID Logo  ; Verma, Raman 2 ; Graham, Christine M 1 ; Lee, Jo 2 ; Tran, Trang 3 ; Richardson, Matthew 2 ; Lecine, Patrick 3 ; Leissner, Philippe 3 ; Berry, Matthew P R 4 ; Wilkinson, Robert J 5 ; Kaiser, Karine 6 ; Rodrigue, Marc 6 ; Woltmann, Gerrit 2   VIAFID ORCID Logo  ; Haldar, Pranabashis 2 ; Anne O’Garra 7   VIAFID ORCID Logo 

 Laboratory of Immunoregulation and Infection, The Francis Crick Institute, London, UK 
 Respiratory Biomedical Research Centre, Institute for Lung Health, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK 
 BIOASTER Microbiology Technology Institute, Lyon, France 
 Department of Respiratory Medicine, Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK 
 Wellcome Centre for Infectious Diseases Research, Africa, Institute for Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, Imperial College London, London, UK; Tuberculosis Laboratory, The Francis Crick Institute, London, UK 
 Medical Diagnostic Discovery Department, bioMérieux SA, Marcy l’Etoile, France 
 Laboratory of Immunoregulation and Infection, The Francis Crick Institute, London, UK; National Heart and Lung Institute, Imperial College London, London, UK 
Pages
1-17
Publication year
2018
Publication date
Jun 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2057097441
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.